Enabling the Promise of Advanced Therapies

Learn More

Enabling Innovation

Our operating companies enable biopharmaceutical innovators and manufacturers to deliver complex therapies to patients more quickly and efficiently.

Cell & Gene Therapies



Committed to advancing the science and art of bioprocessing

We seek out and develop new approaches to biomanufacturing that help enable the promise of advanced therapies.

About Us

Technology Spotlight

Mirus Bio pioneered scientific breakthroughs in non-viral gene delivery and continues to produce industry-leading transfection reagents.

BioMagnetic Solutions has developed advanced immunomagnetic cell separation systems using nanoscale ferrofluids for highly specific cell selection and other bioseparation applications.

Nirrin Technologies provides the next generation of sensors and analytics that enable bioprocess automation with real-time, in-process monitoring for upstream and downstream applications for the biopharma and life science industries.

Acquired by Donaldson Company

Univercells Technologies offers a comprehensive range of intensified and integrated platforms in a low footprint accommodating adherent & suspension-based manufacturing.

Acquired by Biotage AB

Astrea Bioseparations Ltd (formerly Prometic Bioseparations Ltd) has long been established as an expert in affinity chromatography and bioseparations.